- Home
- NUTX vs EYPT Comparison
NUTX vs EYPT Comparison
Compare NUTX & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUTX
- EYPT
- Stock Information
- Founded
- NUTX 2011
- EYPT 1987
- Country
- NUTX United States
- EYPT United States
- Employees
- NUTX N/A
- EYPT N/A
- Industry
- NUTX Retail: Computer Software & Peripheral Equipment
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- NUTX Technology
- EYPT Industrials
- Exchange
- NUTX Nasdaq
- EYPT Nasdaq
- Market Cap
- NUTX 358.7M
- EYPT 427.9M
- IPO Year
- NUTX N/A
- EYPT 2005
- Fundamental
- Price
- NUTX $68.97
- EYPT $4.76
- Analyst Decision
- NUTX Strong Buy
- EYPT Strong Buy
- Analyst Count
- NUTX 2
- EYPT 8
- Target Price
- NUTX $67.50
- EYPT $25.71
- AVG Volume (30 Days)
- NUTX 64.7K
- EYPT 774.3K
- Earning Date
- NUTX 03-31-2025
- EYPT 03-05-2025
- Dividend Yield
- NUTX N/A
- EYPT N/A
- EPS Growth
- NUTX N/A
- EYPT N/A
- EPS
- NUTX 9.71
- EYPT N/A
- Revenue
- NUTX $479,948,633.00
- EYPT $43,273,000.00
- Revenue This Year
- NUTX $25.00
- EYPT N/A
- Revenue Next Year
- NUTX $14.40
- EYPT N/A
- P/E Ratio
- NUTX $7.38
- EYPT N/A
- Revenue Growth
- NUTX 93.80
- EYPT N/A
- 52 Week Low
- NUTX $4.16
- EYPT $4.83
- 52 Week High
- NUTX $76.89
- EYPT $23.65
- Technical
- Relative Strength Index (RSI)
- NUTX 59.22
- EYPT 29.92
- Support Level
- NUTX $45.88
- EYPT $5.87
- Resistance Level
- NUTX $76.89
- EYPT $5.42
- Average True Range (ATR)
- NUTX 5.25
- EYPT 0.38
- MACD
- NUTX 1.77
- EYPT -0.13
- Stochastic Oscillator
- NUTX 70.46
- EYPT 5.03
About NUTX Nutex Health Inc.
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.